VIRUS SAFETY TESTING SERVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

The Global Virus Safety Testing Services Market is estimated to be valued at USD 682.4 million in 2025 and is expected to reach USD 1,987.5 million by 2032, exhibiting a compound annual growth rate (CAGR) of 16.50% from 2025 to 2032. The global virus safety testing services market has witnessed significant growth in recent years, driven by the increasing demand for ensuring the safety and quality of biopharmaceutical products. Virus safety testing is a critical aspect of the biopharmaceutical manufacturing process, as it helps to identify and eliminate potential viral contaminants that could pose a threat to patient safety. The market encompasses a range of services, including viral clearance studies, viral inactivation studies, and virus detection and identification. With the growing complexity of biopharmaceutical products and the stringent regulatory requirements for ensuring their safety, the demand for specialized virus safety testing services is expected to continue to rise in the coming years.

Market Dynamics:

The global virus safety testing services market is driven by several factors, including the increasing prevalence of chronic diseases, the growing demand for biopharmaceutical products, and the stringent regulatory requirements for ensuring the safety and quality of these products. The rising incidence of chronic diseases such as cancer, diabetes, and autoimmune disorders has led to an increased demand for biopharmaceutical products, which, in turn, has fueled the growth of the virus safety testing services market. In addition, the increasing complexity of biopharmaceutical products, such as monoclonal antibodies and recombinant proteins, has created a need for specialized testing services to ensure their safety and efficacy. However, the high cost of virus safety testing services and the lack of standardized protocols for testing are some of the factors that could restrain the growth of the market. Despite these challenges, the market offers significant opportunities for growth, particularly in emerging markets such as Asia Pacific and Latin America, where the demand for biopharmaceutical products is increasing rapidly.

Key Features of the Study:

• This report provides in-depth analysis of the global virus safety testing services market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global virus safety testing services market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Charles River Laboratories, Lonza Group, Merck KGaA, WuXi AppTec, SGS SA, IDEXX Laboratories, Thermo Fisher Scientific, Eurofins Scientific, Abbot Laboratories, Becton, Dickinson and Company, GenScript Biotech Corporation, Viropro Inc., PPD Inc., and Catalent Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global virus safety testing services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global virus safety testing services market

Market Segmentation

•  Testing Type Insights (Revenue, USD Mn, 2020 - 2032)
• • Viral Detection Testing
  • Viral Clearance Testing
  • Adventitious Virus Testing
  • Viral Inactivation Services
  • Antibody Production Tests
  • Retrovirus Tests
  • Other Virus Safety Tests
•  Application Insights (Revenue, USD Mn, 2020 - 2032)
• • Vaccines
  • Antibodies
  • Gene and Cell Therapy
  • Blood Product Safety
  • Tissue & Tissue-based Products
  • Regenerative Medicine
  • Other Applications
•  End User Insights (Revenue, USD Mn, 2020 - 2032)
• • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Academic and Research Institutes
  • Others
• Regional Insights (Revenue, USD Mn, 2020 - 2032)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Charles River Laboratories
  • Lonza Group
  • Merck KGaA
  • WuXi AppTec
  • SGS SA
  • IDEXX Laboratories
  • Thermo Fisher Scientific
  • Eurofins Scientific
  • Abbot Laboratories
  • Becton, Dickinson and Company
  • GenScript Biotech Corporation
  • Viropro Inc.
  • PPD Inc.
  • Catalent Inc.